Aptamer delivery of siRNA, radiopharmaceutics and chemotherapy agents in cancer
Autor(a) principal: | |
---|---|
Data de Publicação: | 2017 |
Outros Autores: | , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da FIOCRUZ (ARCA) |
Texto Completo: | https://www.arca.fiocruz.br/handle/icict/32010 |
Resumo: | Instituto de Radioproteção e Dosimetria. Comissão Nacional de Energia Nuclear. Laboratório de Radiobiologia. Divisão de Física Médica. Rio de Janeiro, RJ, Brasil. |
id |
CRUZ_3d63723a102b7cbcd685775544a2b24e |
---|---|
oai_identifier_str |
oai:www.arca.fiocruz.br:icict/32010 |
network_acronym_str |
CRUZ |
network_name_str |
Repositório Institucional da FIOCRUZ (ARCA) |
repository_id_str |
2135 |
spelling |
Almeida, Carlos E. B. deAlves, Lais NascimentoRocha, Henrique F.Cabral Neto, Januário BispoMissailidis, Sotiris2019-03-08T19:35:17Z2019-03-08T19:35:17Z2017ALMEIDA, Carlos E. B. de et al. Aptamer delivery of siRNA, radiopharmaceutics and chemotherapy agents in cancer. International Journal Of Pharmaceutics, Amsterdam, v. 525, n. 2, p.334-342, 2017.1873-3476https://www.arca.fiocruz.br/handle/icict/3201010.1016/j.ijpharm.2017.03.086engAptamer delivery of siRNA, radiopharmaceutics and chemotherapy agents in cancerinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleInstituto de Radioproteção e Dosimetria. Comissão Nacional de Energia Nuclear. Laboratório de Radiobiologia. Divisão de Física Médica. Rio de Janeiro, RJ, Brasil.Instituto de Radioproteção e Dosimetria. Comissão Nacional de Energia Nuclear. Laboratório de Radiobiologia. Divisão de Física Médica. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos. Rio de Janeiro, RJ, Brasil.Instituto de Radioproteção e Dosimetria. Comissão Nacional de Energia Nuclear. Laboratório de Radiobiologia. Divisão de Física Médica. Rio de Janeiro, RJ, Brasil / Universidade Federal do Rio de Janeiro. Instituto de Biofísica Carlos Chagas Filho. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos. Rio de Janeiro, RJ, Brasil.Aptamers are oligonucleotide reagents with high affinity and specificity, which among other therapeutic and diagnostic applications have the capability of acting as delivery agents. Thus, aptamers are capable of carrying small molecules, nanoparticles, radiopharmaceuticals or fluorescent agents as well as nucleic acid therapeutics specifically to their target cells. In most cases, the molecules may possess interesting therapeutic properties, but their lack of specificity for a particular cell type, or ability to internalise in such a cell, hinders their clinical development, or cause unwanted side effects. Thus, chemotherapy or radiotherapy agents, famous for their side effects, can be coupled to aptamers for specific delivery. Equally, siRNA have great therapeutic potential and specificity, but one of their shortcomings remain the delivery and internalisation into cells. Various methodologies have been proposed to date, including aptamers, to resolve this problem. Therapeutic or imaging reagents benefit from the adaptability and ease of chemical manipulation of aptamers, their high affinity for the specific marker of a cell type, and their internalisation ability via cell mediated endocytosis. In this review paper, we explore the potential of the aptamers as delivery agents and offer an update on current status and latest advancements.AptamersCancerChemotherapysiRNARadiopharmaceuticsinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txttext/plain1748https://www.arca.fiocruz.br/bitstream/icict/32010/1/license.txt8a4605be74aa9ea9d79846c1fba20a33MD51ORIGINALF09-1-s2.0-S0378517317302740-main.pdfapplication/pdf1028133https://www.arca.fiocruz.br/bitstream/icict/32010/2/F09-1-s2.0-S0378517317302740-main.pdf737e8f1013224eadc51e5db7dd6ce9bbMD52TEXTF09-1-s2.0-S0378517317302740-main.pdf.txtF09-1-s2.0-S0378517317302740-main.pdf.txtExtracted texttext/plain62489https://www.arca.fiocruz.br/bitstream/icict/32010/3/F09-1-s2.0-S0378517317302740-main.pdf.txt9c4f19d6caf30388e9bbdef73c6cd4d7MD53icict/320102019-04-04 02:05:10.034oai:www.arca.fiocruz.br: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Repositório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352019-04-04T05:05:10Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false |
dc.title.pt_BR.fl_str_mv |
Aptamer delivery of siRNA, radiopharmaceutics and chemotherapy agents in cancer |
title |
Aptamer delivery of siRNA, radiopharmaceutics and chemotherapy agents in cancer |
spellingShingle |
Aptamer delivery of siRNA, radiopharmaceutics and chemotherapy agents in cancer Almeida, Carlos E. B. de Aptamers Cancer Chemotherapy siRNA Radiopharmaceutics |
title_short |
Aptamer delivery of siRNA, radiopharmaceutics and chemotherapy agents in cancer |
title_full |
Aptamer delivery of siRNA, radiopharmaceutics and chemotherapy agents in cancer |
title_fullStr |
Aptamer delivery of siRNA, radiopharmaceutics and chemotherapy agents in cancer |
title_full_unstemmed |
Aptamer delivery of siRNA, radiopharmaceutics and chemotherapy agents in cancer |
title_sort |
Aptamer delivery of siRNA, radiopharmaceutics and chemotherapy agents in cancer |
author |
Almeida, Carlos E. B. de |
author_facet |
Almeida, Carlos E. B. de Alves, Lais Nascimento Rocha, Henrique F. Cabral Neto, Januário Bispo Missailidis, Sotiris |
author_role |
author |
author2 |
Alves, Lais Nascimento Rocha, Henrique F. Cabral Neto, Januário Bispo Missailidis, Sotiris |
author2_role |
author author author author |
dc.contributor.author.fl_str_mv |
Almeida, Carlos E. B. de Alves, Lais Nascimento Rocha, Henrique F. Cabral Neto, Januário Bispo Missailidis, Sotiris |
dc.subject.en.pt_BR.fl_str_mv |
Aptamers Cancer Chemotherapy siRNA Radiopharmaceutics |
topic |
Aptamers Cancer Chemotherapy siRNA Radiopharmaceutics |
description |
Instituto de Radioproteção e Dosimetria. Comissão Nacional de Energia Nuclear. Laboratório de Radiobiologia. Divisão de Física Médica. Rio de Janeiro, RJ, Brasil. |
publishDate |
2017 |
dc.date.issued.fl_str_mv |
2017 |
dc.date.accessioned.fl_str_mv |
2019-03-08T19:35:17Z |
dc.date.available.fl_str_mv |
2019-03-08T19:35:17Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.citation.fl_str_mv |
ALMEIDA, Carlos E. B. de et al. Aptamer delivery of siRNA, radiopharmaceutics and chemotherapy agents in cancer. International Journal Of Pharmaceutics, Amsterdam, v. 525, n. 2, p.334-342, 2017. |
dc.identifier.uri.fl_str_mv |
https://www.arca.fiocruz.br/handle/icict/32010 |
dc.identifier.issn.pt_BR.fl_str_mv |
1873-3476 |
dc.identifier.doi.none.fl_str_mv |
10.1016/j.ijpharm.2017.03.086 |
identifier_str_mv |
ALMEIDA, Carlos E. B. de et al. Aptamer delivery of siRNA, radiopharmaceutics and chemotherapy agents in cancer. International Journal Of Pharmaceutics, Amsterdam, v. 525, n. 2, p.334-342, 2017. 1873-3476 10.1016/j.ijpharm.2017.03.086 |
url |
https://www.arca.fiocruz.br/handle/icict/32010 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da FIOCRUZ (ARCA) instname:Fundação Oswaldo Cruz (FIOCRUZ) instacron:FIOCRUZ |
instname_str |
Fundação Oswaldo Cruz (FIOCRUZ) |
instacron_str |
FIOCRUZ |
institution |
FIOCRUZ |
reponame_str |
Repositório Institucional da FIOCRUZ (ARCA) |
collection |
Repositório Institucional da FIOCRUZ (ARCA) |
bitstream.url.fl_str_mv |
https://www.arca.fiocruz.br/bitstream/icict/32010/1/license.txt https://www.arca.fiocruz.br/bitstream/icict/32010/2/F09-1-s2.0-S0378517317302740-main.pdf https://www.arca.fiocruz.br/bitstream/icict/32010/3/F09-1-s2.0-S0378517317302740-main.pdf.txt |
bitstream.checksum.fl_str_mv |
8a4605be74aa9ea9d79846c1fba20a33 737e8f1013224eadc51e5db7dd6ce9bb 9c4f19d6caf30388e9bbdef73c6cd4d7 |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 |
repository.name.fl_str_mv |
Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ) |
repository.mail.fl_str_mv |
repositorio.arca@fiocruz.br |
_version_ |
1813009233159913472 |